NightstaRx
Develops gene therapies to cure retinal dystrophies
NightstaRx has raised €32M across 1 funding round from 1 investor, most recently a Series B round in Nov 2015. Based in London, UK; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€32M
€31,769,084
Funding rounds
1
Investors
1
distinct backers
Active since
2015-11
latest 2015-11
Funding by year
EUR raised per yearNightstaRx — funding by year — interactive chart.
Data table
| NightstaRx — funding by year | |
|---|---|
| 2015 | €32M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-11-01 | Series B | €32M | New Enterprise Associates | View deal → |